Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4416.22% is 90% above its 1-year average of -42841.69%, near the high end of its 1-year range (-225766.67%–14482.19%).
89.69% above its 12-month average of -42841.69%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): -225766.67%.
NET PROFIT MARGIN
-4416.22%
NET PROFIT MARGIN AVG TTM
-42841.69%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-441.54%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+89.69%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-900.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$109.36M
Net Profit Margin
-4416.22%
TTM Avg
-42841.69%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109.14M
Net Profit Margin
-2955.63%
TTM Avg
-2231.78%
3Y Avg
-3480.44%
5Y Avg
-3216.57%
Market Cap
$108.30M
Net Profit Margin
31.95%
TTM Avg
15.97%
3Y Avg
7.99%
5Y Avg
5.33%
Market Cap
$109.07M
Net Profit Margin
-14.78%
TTM Avg
-35.00%
3Y Avg
-39.46%
5Y Avg
-38.67%
Market Cap
$109.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$107.28M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1332.08%
Market Cap
$107.43M
Net Profit Margin
-33.92%
TTM Avg
-11.74%
3Y Avg
-13.15%
5Y Avg
-11.88%
Market Cap
$113.01M
Net Profit Margin
-114.77%
TTM Avg
-120.72%
3Y Avg
-96.63%
5Y Avg
-81.33%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $109.36M | -4416.22% | -42841.69% | 0.00% | 0.00% |
| Immunic, Inc. (IMUX)vs › | $108.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | -2955.63% | -2231.78% | -3480.44% | -3216.57% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.30M | 31.95% | 15.97% | 7.99% | 5.33% |
| Apyx Medical Corporation (APYX)vs › | $109.07M | -14.78% | -35.00% | -39.46% | -38.67% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.28M | 0.00% | 0.00% | 0.00% | -1332.08% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.43M | -33.92% | -11.74% | -13.15% | -11.88% |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | -114.77% | -120.72% | -96.63% | -81.33% |
| Definitive Healthcare Corp. (DH)vs › | $105.01M | -72.28% | -110.67% | -76.27% | -63.46% |
Operating Margin
-4744.3%
Net Profit Margin
-4416.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -225766.67% |
| 2026-03-31 | -3494.28% |
| 2025-12-31 | 1909.05% |
| 2025-09-30 | 14482.19% |
| 2025-06-30 | -1338.75% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | -172.46% |
| 2019-06-30 | -760.64% |
| 2019-03-31 | -1597.93% |
| 2018-12-31 | -912.17% |
| 2018-09-30 | -1580.54% |
| 2018-06-30 | -1092.38% |
| 2018-03-31 | -976.82% |
| 2017-12-31 | -248.87% |
| 2017-09-30 | -219.61% |
| 2017-06-30 | -1758.59% |
| 2017-03-31 | -2654.22% |
| 2016-12-31 | -6300.06% |
| 2016-09-30 | -2140.86% |
| 2016-06-30 | -4511.47% |
| 2016-03-31 | -356.02% |
| 2015-12-31 | -1695.05% |
| 2015-09-30 | -3468.42% |
| 2015-06-30 | -875.68% |
| 2015-03-31 | -2825.05% |
| 2014-12-31 | -167.19% |